PromaCare-TA / Tranexamic Acid

PromaCare-TA / Tranexamic Acid Featured Umfanekiso
  • PromaCare-TA / Tranexamic Acid

Inkcazelo emfutshane:

I-PromaCare-TA lichiza elenziwe lafana nalawo aveliswe ngabenzi, i-arhente ye-antifibrinolytic ebalulekileyo kuluhlu lwe-WHO. Isetyenziswe njengeyeza lemveli le-hemostatic.Lichiza lokuthintela i-plasminogen kwi-plasmin egazini. I-Tranexamic acid inqanda ngokukhuphisanayo ukusebenza kwe-plasminogen (ngokubophelela kwisizinda se-kringle), ngaloo ndlela inciphisa ukuguqulwa kwe-plasminogen kwi-plasmin (fibrinolysin), i-enzyme ehlisa i-fibrin clots, i-fibrinogen, kunye nezinye iiprotheni ze-plasma, kubandakanywa ne-procoagulant factor V kunye ne-VIII. I-Tranexamic acid iphinda ithintele ngokuthe ngqo umsebenzi we-plasmin, kodwa iidosi eziphezulu ziyafuneka kunezo zifunekayo ukunciphisa ukubunjwa kwe-plasmin.


Iinkcukacha zeMveliso

Iithegi zeMveliso

 

Igama lorhwebo PromaCare-TA
CAS 1197-18-8
Igama lemveliso Tranexamic Acid
Ulwakhiwo lweMichiza
Isicelo Iyeza
Iphakheji 25kgs inetha igubu ngalinye
Imbonakalo Amhlophe okanye aphantse abe mhlophe, amandla ekristale
Isivavanyi 99.0-101.0%
Ukunyibilika Amanzi anyibilikayo
Beka ubomi kwishelufa Iminyaka emi-4
Ugcino Gcina isitya sivaliwe ngokuqinileyo kwaye kwindawo epholileyo. Gcina kude nobushushu.

Isicelo

I-Tranexamic Acid, ekwabizwa ngokuba yi-clotting acid, yi-antifibrinolytic amino acid, enye ye-anticoagulants esetyenziswa ngokuqhelekileyo ekliniki.

Le mveliso ingasetyenziselwa:

1. Ukwenzakala okanye ukopha ngotyando lwedlala lengqula, urethra, imiphunga, ingqondo, isibeleko, idlala lengqula, idlala lengqula, isibindi kunye namanye amalungu atyebileyo kwi-activator ye-plasminogen.

2. Zisetyenziselwa njengama-agent e-thrombolytic, njenge-tissue plasminogen activator (t-PA), i-streptokinase kunye ne-urokinase antagonist.

3. Ukukhutshwa kwesisu okubangelwayo, ukukhutshwa kwe-placenta, ukuzala umntwana oshonile kunye ne-amniotic fluid embolism ebangelwa ukopha kwe-fibrinolytic.

4. I-Menorrhagia, i-hemorrhage yangaphambili yegumbi kunye ne-epistaxis enzima ngokunyuka kwe-fibrinolysis yendawo.

5. Isetyenziselwa ukuthintela okanye ukunciphisa ukuphuma kwegazi emva kokukhutshwa kwezinyo okanye utyando lomlomo kwizigulane ze-hemophilic ezine-factor VIII okanye i-factor IX.

6. Le mveliso iphezulu kunezinye izidakamizwa ze-antifibrinolytic kwi-hemostasis ye-hemorrhage encinci ebangelwa ukuphuka kwe-aneurysm ephakathi, njenge-subarachnoid hemorrhage kunye ne-intracranial aneurysm hemorrhage. Nangona kunjalo, ingqalelo kufuneka ihlawulwe kumngcipheko we-cerebral edema okanye i-cerebral infarction. Ngokumalunga nezigulane ezinzima ezinezibonakaliso zotyando, le mveliso ingasetyenziselwa kuphela njenge-adjuvant.

7. Kunyango lwe-edema ye-vascular hereditary, inokunciphisa inani lokuhlaselwa kunye nobunzima.

8. Izigulane ezine-hemophilia zopha okusebenzayo.

9. Inesiphumo esiqinisekileyo sonyango kwi-chloasma.

  • Ngaphambili:
  • Okulandelayo:

    • IIMVELISO EZINXULUMENEYO